Testosterone cream prescribed for women is most commonly applied to the inner thigh, outer upper arm, lower abdomen, or behind the knee, though some prescriptions call for application directly to the vulvar area for localized effects on sexual function. The site you use matters because skin thickness, blood flow, and local hormone-metabolizing enzymes all vary by body region, which affects how much testosterone actually reaches your bloodstream. Because no testosterone product is currently FDA-approved specifically for women, most prescriptions are compounded or adapted from male formulations at much lower doses, making correct application technique even more important for getting consistent results.
The Most Common Application Sites
Your prescriber will specify a site based on the formulation, the dose, and whether the goal is systemic absorption or a localized effect. For systemic use, the standard recommendation is a large, relatively hairless area of skin that can be covered by clothing afterward. The inner thigh is one of the most frequently recommended sites because the skin there is thin enough for good absorption and the area is naturally protected by clothing, which reduces the risk of transferring the hormone to someone else through skin-to-skin contact. The outer upper arm, lower abdomen, and the area behind the knees are also commonly used.
A few practical rules apply regardless of which site your prescriber chooses. The skin should be clean, dry, and free of cuts or irritation before you apply. Creams absorb in roughly two minutes on clean, dry skin, and you should wait about an hour before bathing, swimming, or allowing anyone else’s skin to touch the application area. Rotating between two or three sites from day to day can help prevent local irritation and may improve consistency of absorption over time.
One site that deserves separate mention is the vulvar or clitoral area. Some clinicians prescribe low-dose testosterone cream directly to the vulva for women experiencing genital symptoms of menopause or certain types of sexual dysfunction. This is a different clinical situation from systemic therapy. Vulvar skin and mucous membranes absorb hormones much more efficiently than arm or thigh skin, so vulvar formulations typically contain a far lower concentration of testosterone. Never substitute a systemic cream for a vulvar one or vice versa without checking with your prescriber.
Why the Application Site Affects What You Absorb
Skin is not a uniform organ. Its thickness, the density of blood vessels beneath it, and the activity of local enzymes all change depending on body region. Thinner skin lets more drug through. Areas with more blood flow carry absorbed testosterone into general circulation faster. And skin cells themselves contain enzymes that can convert testosterone into other hormones, including estrogen and a more potent androgen called DHT, before the testosterone ever reaches your bloodstream.
Research on skin cells has found that human epidermal keratinocytes and dermal fibroblasts actively process sex steroids locally, meaning some of the testosterone you apply gets transformed right at the application site rather than entering circulation unchanged.1PubMed. Intracrine sex steroid synthesis and signaling in human epidermal keratinocytes and dermal fibroblasts This local metabolism is one reason clinicians care about where you put the cream. The inner thigh or abdomen tend to deliver a more predictable systemic dose than, say, the palms or the face, where skin properties differ dramatically.
The vehicle the testosterone is suspended in also affects absorption. Creams, gels, and ointments each interact differently with the skin depending on whether the surface is dry or moist, intact or compromised. A cream formulated for vulvar mucosa behaves very differently from a gel designed for the upper arm, even if both contain the same active ingredient. Choosing the right vehicle for the right site is part of why your pharmacist and prescriber need to coordinate on these details.2PubMed Central. Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
Why Women Use Testosterone Cream in the First Place
The primary evidence-based reason for prescribing testosterone to women is hypoactive sexual desire disorder, or HSDD, a persistent drop in sexual desire that causes personal distress. This condition is most studied in postmenopausal women, though it can occur earlier. A global consensus statement from an international panel of endocrine societies endorsed testosterone therapy specifically for postmenopausal women with HSDD after other causes have been ruled out.3PubMed Central. Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The benefits are real but modest. A large year-long trial of over 800 postmenopausal women with HSDD who were not on estrogen found that a testosterone patch delivering 300 micrograms per day increased the number of satisfying sexual episodes compared to placebo.4PubMed. Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen Earlier trials in surgically menopausal women taking estrogen found similar improvements with a transdermal patch.5PubMed. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women The word “modestly” keeps coming up in the clinical literature, and that framing is honest. Testosterone therapy tends to nudge desire upward, not transform it, and not every woman responds.6PubMed. Testosterone for the Treatment of Hypoactive Sexual Desire Disorder in Perimenopausal and Postmenopausal Women
When testosterone is applied directly to the vulvar area, the goals can be more localized. One study measuring blood flow in the clitoral artery found that six months of testosterone therapy significantly increased clitoral blood flow and improved multiple domains of sexual function, including desire, arousal, lubrication, and orgasm, with no adverse metabolic effects observed.7PubMed Central. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction This kind of localized vascular response is distinct from the systemic effects seen with thigh or arm application and helps explain why some prescribers choose site-specific treatment.
The Dosing Problem With Male Products
No testosterone cream or gel is currently FDA-approved for use in women. Male products like AndroGel and Testim deliver daily doses in the range of 25 to 100 milligrams. Female physiological doses are roughly a tenth of that or less. This mismatch forces most women to use compounded formulations made by specialty pharmacies, which prepare creams at concentrations appropriate for the female dose range.
Compounding introduces its own problems. A study that tested testosterone concentrations in products from multiple compounding pharmacies found striking inconsistency. In one round of testing, only half the pharmacies produced a product within 20 percent of the prescribed dose. In a second round, that number dropped to 30 percent.8PubMed. Accuracy of testosterone concentrations in compounded testosterone products That means a woman faithfully applying the same pea-sized amount every day could be getting wildly different doses depending on which batch she received, or even where in the tube she is. This variability is one of the strongest arguments for regular blood level monitoring and for working with a compounding pharmacy that your prescriber trusts.
If your prescriber has you using a fraction of a male product instead of a compounded cream, the risk is different but equally real. Measuring out one-tenth of a pre-filled pump or a tiny fraction of a foil packet is imprecise, and male gels often have higher alcohol concentrations that can irritate thinner skin. If you are using an off-label male product, ask your prescriber exactly how to measure the dose and whether a compounded alternative might give you more consistent delivery.
How to Monitor Whether Your Dose Is Right
Blood testing is the main way to confirm that your cream is delivering an appropriate amount. The global consensus statement recommends measuring your total testosterone before starting therapy, again three to six weeks after you begin, and then every six months to screen for overuse.3PubMed Central. Global Consensus Position Statement on the Use of Testosterone Therapy for Women The goal is to keep your blood levels within the normal premenopausal range, not above it. Levels that climb above this range do not necessarily produce better results and increase the risk of side effects.
One subtle issue with blood testing is contamination. If you apply testosterone cream with your hands and later have blood drawn from a fingertip, residual testosterone on your skin can artificially inflate the reading. A study comparing capillary fingerstick samples with standard venous blood draws in women using testosterone gel found noticeably higher testosterone concentrations in the fingertip samples, likely due to contamination from fingers used during gel application.9PubMed Central. Steroid profiling by UHPLC-MS/MS in dried blood spots collected from healthy women with and without testosterone gel administration The practical takeaway: wash your hands thoroughly after every application, and when you go for blood work, make sure the draw is from a vein in your arm, not a fingerstick, and that the blood draw happens at a consistent time relative to your last application so results are comparable from visit to visit.
Symptom tracking matters at least as much as the numbers. Your prescriber should be asking about your clinical response, including any changes in desire, energy, or mood, as well as any signs of excess testosterone like acne, oily skin, or unwanted hair growth. If your blood levels are in range but you are not noticing any improvement after three to six months, testosterone therapy may simply not be the right tool for you, and there is no reason to keep increasing the dose.
Transfer Risk to Partners and Children
One of the most serious practical concerns with topical testosterone is secondary exposure, meaning the hormone rubs off onto someone else’s skin. The FDA has required a boxed warning on testosterone gel products since 2009 after reports of adverse events in children and partners who had contact with treated skin.10The Journal of Sexual Medicine. Transfer of Topical Testosterone Preparations to Children or Spouses Most of these cases involved men using high-dose products, but the principle applies to anyone using topical testosterone.
Research on secondary transfer has shown that intensive skin-to-skin contact at the application site does pass measurable amounts of testosterone to a partner, but that covering the site with clothing or showering before contact sharply reduces the transfer.11PubMed Central. Preventing Secondary Exposure to Women from Men Applying a Novel Nestorone/Testosterone Contraceptive Gel The female doses involved in HSDD treatment are far lower than male doses, so the absolute risk of meaningful transfer is smaller. Still, reasonable precautions are straightforward: apply the cream where clothing covers it, wash your hands immediately after, wait at least an hour for full absorption before intimate skin contact, and keep the application area covered or washed before holding children.
Side Effects and the Virilization Question
The concern most women have about testosterone therapy is whether it will cause masculinizing side effects, things like a deeper voice, facial hair, or male-pattern hair loss. At physiologic doses, meaning doses that keep blood levels within the normal premenopausal range, the evidence suggests these effects are uncommon. A review addressing common myths about testosterone in women argued that at appropriate doses, testosterone is not masculinizing, does not cause hoarseness, and may actually increase scalp hair growth rather than cause hair loss.12PubMed. Testosterone therapy in women: myths and misconceptions
That said, the risk is dose-dependent. This is where application site, formulation accuracy, and monitoring all come together. If your compounded cream is substantially more concentrated than prescribed, or if you are applying it to a highly absorbent area without realizing the dose is too high, your blood levels can creep above the premenopausal range and side effects become more likely. Acne and oily skin are usually the earliest warning signs and tend to resolve if the dose is reduced. Voice changes, on the other hand, can be slow to develop and may not fully reverse. Your prescriber should be screening for these at every follow-up.
Cardiovascular and Metabolic Effects
The long-term cardiovascular safety of testosterone therapy in women remains genuinely uncertain. A review of seven studies found a split picture: about half reported improvements in cardiovascular markers like functional capacity, muscle strength, cholesterol levels, and lean body mass, while about half reported concerning changes including lower HDL cholesterol (the protective kind), increased visceral fat, and higher insulin resistance.13PubMed Central. The Impact of Testosterone Therapy on Cardiovascular Risk Among Postmenopausal Women The fact that positive and negative findings show up in roughly equal measure tells you the evidence is not settled.
The clitoral blood flow study mentioned earlier found no significant changes in cholesterol, triglycerides, fasting glucose, insulin, or hemoglobin A1c across six months of treatment, which is reassuring for shorter-term use.7PubMed Central. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction But most studies of testosterone in women are relatively short, often a year or less, and no large, long-duration cardiovascular outcome trial has been conducted. The global consensus position acknowledges this evidence gap and recommends that women on testosterone therapy have lipid panels and metabolic markers checked periodically.
Why There Is No “Androgen Deficiency” Diagnosis for Women
One of the most confusing things about testosterone therapy for women is that there is no formally recognized condition called “androgen deficiency” in the female medical literature. The Endocrine Society pointed out years ago that research on therapeutic androgens in women has been held back by the lack of a clear definition of such a syndrome and by poor endocrine measurement tools.14The Journal of Clinical Endocrinology & Metabolism. Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline More recent guidelines echo this: there is no blood test threshold below which a woman is deemed “testosterone deficient” the way there is for men.6PubMed. Testosterone for the Treatment of Hypoactive Sexual Desire Disorder in Perimenopausal and Postmenopausal Women
This matters practically because some clinics market testosterone therapy to women based on a low blood level alone, without evaluating for HSDD or ruling out other causes of symptoms like fatigue or low mood. The current consensus is clear: testosterone therapy in women is indicated for distressing low desire after other causes have been excluded, not for a number on a lab slip. If a provider offers you testosterone cream based solely on a low blood level, that is a red flag worth questioning.
Effects Beyond Sexual Function
While HSDD is the only indication with strong enough evidence for formal guideline endorsement, researchers are interested in whether testosterone does other useful things for women. Testosterone is after all the most abundant biologically active sex hormone in the female body, present at concentrations several times higher than estradiol even after menopause.12PubMed. Testosterone therapy in women: myths and misconceptions
Muscle and bone health are plausible targets. Hormone replacement in postmenopausal women has been shown to reduce age-related muscle loss, improve fast muscle function like power output, limit fat accumulation in skeletal muscle, and boost the rate of muscle protein synthesis after resistance training.15SpringerLink (Biogerontology). Sex hormones and skeletal muscle weakness Most of that research focuses on estrogen-based HRT rather than testosterone specifically, but the overlapping biology suggests testosterone could contribute. The evidence here is preliminary enough that no guideline currently recommends testosterone cream for musculoskeletal health in women, but it is an active area of research and one reason the global consensus called for larger and longer trials.
Mood is another area where women sometimes report improvements on testosterone, though separating a direct hormonal effect from the secondary benefit of improved sexual function and self-image is tricky in the available studies. The consensus position does not endorse testosterone therapy for mood or energy complaints on their own, and most of the anecdotal reports of mood benefits come from women who were also being treated for HSDD.
Breast Tissue and Testosterone
The question of whether testosterone therapy affects breast cancer risk comes up often and deserves a direct answer: the data are not sufficient to give one. Testosterone can theoretically go in two directions in breast tissue. It can act directly through androgen receptors, which in animal studies appears to limit breast cell proliferation, or it can be converted locally into estrogen, which promotes it. Research in primates has suggested that testosterone may function as a natural brake on estrogen’s stimulation of breast tissue, but translating that to clinical recommendations in humans requires evidence that does not yet exist at scale.16Oxford Academic. Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women Current guidelines neither warn against testosterone in women with average breast cancer risk nor claim it is protective. If you have a personal or strong family history of breast cancer, this is worth a specific conversation with your oncologist before starting therapy.